000 01463 a2200421 4500
005 20250516062622.0
264 0 _c20120322
008 201203s 0 0 eng d
022 _a1502-7732
024 7 _a10.3109/03009742.2011.610032
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHesselstrand, R
245 0 0 _aScleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factor.
_h[electronic resource]
260 _bScandinavian journal of rheumatology
_cFeb 2012
300 _a39-43 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntibodies, Antinuclear
_xblood
650 0 4 _aCase-Control Studies
650 0 4 _aCohort Studies
650 0 4 _aHumans
650 0 4 _aKidney
_xphysiopathology
650 0 4 _aKidney Diseases
_xetiology
650 0 4 _aMiddle Aged
650 0 4 _aPrognosis
650 0 4 _aRNA Polymerase III
_ximmunology
650 0 4 _aRenal Dialysis
650 0 4 _aRetrospective Studies
650 0 4 _aRisk Factors
650 0 4 _aScleroderma, Systemic
_ximmunology
650 0 4 _aSurvival Rate
650 0 4 _aSweden
700 1 _aScheja, A
700 1 _aWuttge, D M
773 0 _tScandinavian journal of rheumatology
_gvol. 41
_gno. 1
_gp. 39-43
856 4 0 _uhttps://doi.org/10.3109/03009742.2011.610032
_zAvailable from publisher's website
999 _c21274556
_d21274556